Metraipolis › archive › dc_b9c8df6cc8dd

The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40796268
DOI
10.1152/ajpheart.00363.2025
License (as archived)
solo-consultazione
Archived
2026-11-10T17:26:02.217Z
SHA-256 of the archived text
d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231
Stable URL of this page
https://metraipolis.com/documento/dc_b9c8df6cc8dd

How to cite

The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268 — Europe PMC (en), https://europepmc.org/article/MED/40796268 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9c8df6cc8dd (Metraipolis archive dc_b9c8df6cc8dd, sha256 d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231)
BibTeX
@misc{dcb9c8df6cc8dd,
  title = {The sodium/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Nav1.5 channels — Europe PMC PMID:40796268},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40796268},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9c8df6cc8dd; sha256 d68a2f960a00d9b91c7bf768cafb891c4c840c9134c00215519ff0202ae10231},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40796268. Agents can read the archived copy with the MCP tool read_document.